Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial

Fig. 4

Longitudinal evaluation of serial changes in the NIHS and Barthel index in each group of patients A Time courses of the National Institute of Health Stroke Scale (NIHSS) scores in the cell-treated group and control group. The results were analyzed via repeated-measures ANOVA, with p < 0.0001 in cell-treated group and p < 0.001 in control group. B Time courses of the Barthel index in the cell-treated group and control group. The results were analyzed via repeated-measures ANOVA, with p < 0.0001 in the cell-treated group and p < 0.0001 in the control group

Back to article page